Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans

Rationale Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning t...

Full description

Saved in:
Bibliographic Details
Published inPsychopharmacologia Vol. 197; no. 3; pp. 421 - 431
Main Authors Ersche, Karen D., Roiser, Jonathan P., Robbins, Trevor W., Sahakian, Barbara J.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer-Verlag 01.04.2008
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Rationale Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning task, in chronic drug users and controls. Materials and methods Five groups were compared: chronic amphetamine users ( n = 30); chronic cocaine users ( n = 27); chronic opiate users ( n = 42); former drug users of psychostimulants and opiates ( n = 26); and healthy non-drug-taking control volunteers ( n = 25). Participants had to make a forced choice between two alternative stimuli on each trial to acquire a stimulus–reward association on the basis of degraded feedback and subsequently to reverse their responses when the reward contingencies changed. Results Chronic cocaine users demonstrated little behavioural change in response to the change in reward contingencies, as reflected by perseverative responding to the previously rewarded stimulus. Perseverative responding was observed in cocaine users regardless of whether they completed the reversal stage successfully. Task performance in chronic users of amphetamines and opiates, as well as in former drug users, was not measurably impaired. Conclusion Our findings provide convincing evidence for response perseveration in cocaine users during probabilistic reversal-learning. Pharmacological differences between amphetamine and cocaine, in particular their respective effects on the 5-HT system, may account for the divergent task performance between the two psychostimulant user groups. The inability to reverse responses according to changes in reinforcement contingencies may underlie the maladaptive behaviour patterns observed in chronic cocaine users but not in chronic users of amphetamines or opiates.
AbstractList Rationale Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning task, in chronic drug users and controls. Materials and methods Five groups were compared: chronic amphetamine users ( n = 30); chronic cocaine users ( n = 27); chronic opiate users ( n = 42); former drug users of psychostimulants and opiates ( n = 26); and healthy non-drug-taking control volunteers ( n = 25). Participants had to make a forced choice between two alternative stimuli on each trial to acquire a stimulus–reward association on the basis of degraded feedback and subsequently to reverse their responses when the reward contingencies changed. Results Chronic cocaine users demonstrated little behavioural change in response to the change in reward contingencies, as reflected by perseverative responding to the previously rewarded stimulus. Perseverative responding was observed in cocaine users regardless of whether they completed the reversal stage successfully. Task performance in chronic users of amphetamines and opiates, as well as in former drug users, was not measurably impaired. Conclusion Our findings provide convincing evidence for response perseveration in cocaine users during probabilistic reversal-learning. Pharmacological differences between amphetamine and cocaine, in particular their respective effects on the 5-HT system, may account for the divergent task performance between the two psychostimulant user groups. The inability to reverse responses according to changes in reinforcement contingencies may underlie the maladaptive behaviour patterns observed in chronic cocaine users but not in chronic users of amphetamines or opiates.
Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning task, in chronic drug users and controls. Five groups were compared: chronic amphetamine users (n = 30); chronic cocaine users (n = 27); chronic opiate users (n = 42); former drug users of psychostimulants and opiates (n = 26); and healthy non-drug-taking control volunteers (n = 25). Participants had to make a forced choice between two alternative stimuli on each trial to acquire a stimulus-reward association on the basis of degraded feedback and subsequently to reverse their responses when the reward contingencies changed. Chronic cocaine users demonstrated little behavioural change in response to the change in reward contingencies, as reflected by perseverative responding to the previously rewarded stimulus. Perseverative responding was observed in cocaine users regardless of whether they completed the reversal stage successfully. Task performance in chronic users of amphetamines and opiates, as well as in former drug users, was not measurably impaired. Our findings provide convincing evidence for response perseveration in cocaine users during probabilistic reversal-learning. Pharmacological differences between amphetamine and cocaine, in particular their respective effects on the 5-HT system, may account for the divergent task performance between the two psychostimulant user groups. The inability to reverse responses according to changes in reinforcement contingencies may underlie the maladaptive behaviour patterns observed in chronic cocaine users but not in chronic users of amphetamines or opiates.
Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning task, in chronic drug users and controls.RATIONALEChronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning task, in chronic drug users and controls.Five groups were compared: chronic amphetamine users (n = 30); chronic cocaine users (n = 27); chronic opiate users (n = 42); former drug users of psychostimulants and opiates (n = 26); and healthy non-drug-taking control volunteers (n = 25). Participants had to make a forced choice between two alternative stimuli on each trial to acquire a stimulus-reward association on the basis of degraded feedback and subsequently to reverse their responses when the reward contingencies changed.MATERIALS AND METHODSFive groups were compared: chronic amphetamine users (n = 30); chronic cocaine users (n = 27); chronic opiate users (n = 42); former drug users of psychostimulants and opiates (n = 26); and healthy non-drug-taking control volunteers (n = 25). Participants had to make a forced choice between two alternative stimuli on each trial to acquire a stimulus-reward association on the basis of degraded feedback and subsequently to reverse their responses when the reward contingencies changed.Chronic cocaine users demonstrated little behavioural change in response to the change in reward contingencies, as reflected by perseverative responding to the previously rewarded stimulus. Perseverative responding was observed in cocaine users regardless of whether they completed the reversal stage successfully. Task performance in chronic users of amphetamines and opiates, as well as in former drug users, was not measurably impaired.RESULTSChronic cocaine users demonstrated little behavioural change in response to the change in reward contingencies, as reflected by perseverative responding to the previously rewarded stimulus. Perseverative responding was observed in cocaine users regardless of whether they completed the reversal stage successfully. Task performance in chronic users of amphetamines and opiates, as well as in former drug users, was not measurably impaired.Our findings provide convincing evidence for response perseveration in cocaine users during probabilistic reversal-learning. Pharmacological differences between amphetamine and cocaine, in particular their respective effects on the 5-HT system, may account for the divergent task performance between the two psychostimulant user groups. The inability to reverse responses according to changes in reinforcement contingencies may underlie the maladaptive behaviour patterns observed in chronic cocaine users but not in chronic users of amphetamines or opiates.CONCLUSIONOur findings provide convincing evidence for response perseveration in cocaine users during probabilistic reversal-learning. Pharmacological differences between amphetamine and cocaine, in particular their respective effects on the 5-HT system, may account for the divergent task performance between the two psychostimulant user groups. The inability to reverse responses according to changes in reinforcement contingencies may underlie the maladaptive behaviour patterns observed in chronic cocaine users but not in chronic users of amphetamines or opiates.
Rationale: Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning task, in chronic drug users and controls. Materials and methods: Five groups were compared: chronic amphetamine users (n = 30); chronic cocaine users (n = 27); chronic opiate users (n = 42); former drug users of psychostimulants and opiates (n = 26); and healthy non-drug-taking control volunteers (n = 25). Participants had to make a forced choice between two alternative stimuli on each trial to acquire a stimulus-reward association on the basis of degraded feedback and subsequently to reverse their responses when the reward contingencies changed. Results: Chronic cocaine users demonstrated little behavioural change in response to the change in reward contingencies, as reflected by perseverative responding to the previously rewarded stimulus. Perseverative responding was observed in cocaine users regardless of whether they completed the reversal stage successfully. Task performance in chronic users of amphetamines and opiates, as well as in former drug users, was not measurably impaired. Conclusion: Our findings provide convincing evidence for response perseveration in cocaine users during probabilistic reversal-learning. Pharmacological differences between amphetamine and cocaine, in particular their respective effects on the 5-HT system, may account for the divergent task performance between the two psychostimulant user groups. The inability to reverse responses according to changes in reinforcement contingencies may underlie the maladaptive behaviour patterns observed in chronic cocaine users but not in chronic users of amphetamines or opiates.
Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning task, in chronic drug users and controls. Five groups were compared: chronic amphetamine users (n = 30); chronic cocaine users (n = 27); chronic opiate users (n = 42); former drug users of psychostimulants and opiates (n = 26); and healthy non-drug-taking control volunteers (n = 25). Participants had to make a forced choice between two alternative stimuli on each trial to acquire a stimulus-reward association on the basis of degraded feedback and subsequently to reverse their responses when the reward contingencies changed. Chronic cocaine users demonstrated little behavioural change in response to the change in reward contingencies, as reflected by perseverative responding to the previously rewarded stimulus. Perseverative responding was observed in cocaine users regardless of whether they completed the reversal stage successfully. Task performance in chronic users of amphetamines and opiates, as well as in former drug users, was not measurably impaired. Our findings provide convincing evidence for response perseveration in cocaine users during probabilistic reversal-learning. Pharmacological differences between amphetamine and cocaine, in particular their respective effects on the 5-HT system, may account for the divergent task performance between the two psychostimulant user groups. The inability to reverse responses according to changes in reinforcement contingencies may underlie the maladaptive behaviour patterns observed in chronic cocaine users but not in chronic users of amphetamines or opiates. [PUBLICATION ABSTRACT]
Author Robbins, Trevor W.
Roiser, Jonathan P.
Sahakian, Barbara J.
Ersche, Karen D.
Author_xml – sequence: 1
  givenname: Karen D.
  surname: Ersche
  fullname: Ersche, Karen D.
  email: ke220@cam.ac.uk
  organization: Department of Psychiatry, Brain Mapping Unit, School of Clinical Medicine, University of Cambridge, Behavioural and Clinical Neurosciences Institute, University of Cambridge
– sequence: 2
  givenname: Jonathan P.
  surname: Roiser
  fullname: Roiser, Jonathan P.
  organization: Behavioural and Clinical Neurosciences Institute, University of Cambridge, Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Institute of Cognitive Neuroscience
– sequence: 3
  givenname: Trevor W.
  surname: Robbins
  fullname: Robbins, Trevor W.
  organization: Behavioural and Clinical Neurosciences Institute, University of Cambridge, Department of Experimental Psychology, University of Cambridge
– sequence: 4
  givenname: Barbara J.
  surname: Sahakian
  fullname: Sahakian, Barbara J.
  organization: Behavioural and Clinical Neurosciences Institute, University of Cambridge, Department of Psychiatry, School of Clinical Medicine, University of Cambridge
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20233315$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18214445$$D View this record in MEDLINE/PubMed
BookMark eNqFkkuLFDEQx4OsuLOrH8CLBEFvrXl2Zy-CDL5gwYueQyZdmc7SnbRJesRvb5oZd3VBzSVF6lf_1OsCnYUYAKGnlLyihHSvMyGM8qaaDSWSNvQB2lDBWcNIx87QhhDOG06lOkcXOd-QeoQSj9A5VYwKIeQGwXZIMXiLbbTGB8C7peAQC7andzPNAxQzrb4lA_YZm5yj9aZAj7_7MuAZUoYDJFP8AXCCPMfQ-7DHPuBhmUzIj9FDZ8YMT073Jfr6_t2X7cfm-vOHT9u3140VSpbGWCeoYxQk9M4pYahtoTdcCRCSCbDWsSvp-p0jPbMdJ6yzpu0J6SljHBy_RG-OuvOym6C3EEoyo56Tn0z6oaPx-k9P8IPex4PmnZKU0yrw8iSQ4rcFctGTzxbG0QSIS9atkm3LBPkvyEhLOBFdBZ_fA2_ikkLtgmZUXUlVZ1GhZ7_nfZvwrzlV4MUJMNma0SUTrM-3HCOM8zroytEjZ1PMOYG7kyJ63Rl93Bm9muvO6LXm7l6M9aXOMq4t8uM_I9kxMtdfwh7SXW1_D_oJTnnW-Q
CODEN PSYPAG
CitedBy_id crossref_primary_10_1007_s00213_011_2550_7
crossref_primary_10_1016_j_biopsych_2020_06_020
crossref_primary_10_1038_npp_2009_127
crossref_primary_10_1111_nyas_12388
crossref_primary_10_3389_fpsyt_2016_00034
crossref_primary_10_1016_j_nlm_2016_01_017
crossref_primary_10_1111_j_1369_1600_2011_00351_x
crossref_primary_10_1007_s00213_018_4922_8
crossref_primary_10_1111_ejn_12644
crossref_primary_10_1016_j_drugalcdep_2013_09_029
crossref_primary_10_1038_s41398_019_0445_2
crossref_primary_10_1196_annals_1441_030
crossref_primary_10_1523_JNEUROSCI_0029_12_2012
crossref_primary_10_1016_j_pnpbp_2017_02_024
crossref_primary_10_1038_s41386_021_01136_w
crossref_primary_10_1080_10826084_2016_1178293
crossref_primary_10_1111_j_1460_9568_2012_08000_x
crossref_primary_10_1111_tra_12295
crossref_primary_10_1016_j_neubiorev_2018_11_015
crossref_primary_10_1111_j_1369_1600_2008_00134_x
crossref_primary_10_1016_j_drugalcdep_2011_09_025
crossref_primary_10_1007_s00213_010_1833_8
crossref_primary_10_1016_j_biopsych_2011_01_014
crossref_primary_10_1002_brb3_65
crossref_primary_10_1093_cercor_bhac459
crossref_primary_10_1002_cpmo_82
crossref_primary_10_1007_s00213_017_4689_3
crossref_primary_10_1016_j_neuropharm_2011_04_007
crossref_primary_10_1111_j_1369_1600_2009_00200_x
crossref_primary_10_1093_cercor_bhaa277
crossref_primary_10_1523_JNEUROSCI_1440_13_2013
crossref_primary_10_1017_S0140525X20000357
crossref_primary_10_1007_s00213_014_3534_1
crossref_primary_10_1016_j_biopsych_2020_02_017
crossref_primary_10_1016_j_bbr_2013_12_025
crossref_primary_10_1098_rstb_2008_0102
crossref_primary_10_1016_j_pbb_2020_172994
crossref_primary_10_1177_2043808718779431
crossref_primary_10_1192_bjp_bp_114_152223
crossref_primary_10_1016_j_bpsgos_2023_06_001
crossref_primary_10_1038_s41386_020_0600_8
crossref_primary_10_1016_j_neuropharm_2013_06_031
crossref_primary_10_1196_annals_1441_020
crossref_primary_10_1016_j_bbr_2012_09_005
crossref_primary_10_1177_0269881120926674
crossref_primary_10_1016_j_ddmod_2009_03_011
crossref_primary_10_1016_j_biopsych_2014_11_017
crossref_primary_10_1523_JNEUROSCI_1755_20_2020
crossref_primary_10_1016_j_biopsych_2012_08_018
crossref_primary_10_1038_npp_2016_147
crossref_primary_10_1101_lm_036251_114
crossref_primary_10_1016_j_pscychresns_2012_01_006
crossref_primary_10_1016_j_biopsych_2018_12_017
crossref_primary_10_1523_JNEUROSCI_2777_14_2015
crossref_primary_10_3109_00952990_2014_939752
crossref_primary_10_3389_fpsyt_2023_1170541
crossref_primary_10_1016_j_bbr_2020_112815
crossref_primary_10_3758_s13415_023_01139_8
crossref_primary_10_1038_s41386_022_01514_y
crossref_primary_10_3389_fnhum_2015_00343
crossref_primary_10_1002_da_20897
crossref_primary_10_1016_j_drugalcdep_2015_03_021
crossref_primary_10_1016_j_pbb_2010_04_012
crossref_primary_10_1016_j_psychres_2009_11_024
crossref_primary_10_1097_FBP_0000000000000771
crossref_primary_10_1007_s00213_011_2485_z
crossref_primary_10_1162_jocn_a_01784
crossref_primary_10_1016_j_peptides_2009_09_027
crossref_primary_10_1007_s00213_014_3598_y
crossref_primary_10_1007_s00213_019_05325_w
crossref_primary_10_1016_j_euroneuro_2015_12_003
crossref_primary_10_1177_1073191116654218
crossref_primary_10_1016_j_neuropsychologia_2011_02_023
crossref_primary_10_1016_j_biopsych_2012_12_002
crossref_primary_10_1016_j_jsat_2021_108291
crossref_primary_10_1093_cercor_bhy276
crossref_primary_10_1007_s00213_013_3135_4
crossref_primary_10_1016_j_drugalcdep_2019_107610
crossref_primary_10_1038_npp_2017_159
crossref_primary_10_1016_j_pbb_2009_05_013
crossref_primary_10_1016_j_cortex_2021_07_002
crossref_primary_10_3389_fpsyt_2020_588768
crossref_primary_10_1080_00952990_2017_1355919
crossref_primary_10_1016_j_neubiorev_2012_04_006
crossref_primary_10_3389_fnbeh_2016_00154
crossref_primary_10_1016_j_neubiorev_2016_04_006
crossref_primary_10_1038_npp_2009_48
crossref_primary_10_1093_ijnp_pyad019
crossref_primary_10_1007_s40473_016_0068_3
crossref_primary_10_1016_j_biopsych_2020_08_008
crossref_primary_10_1007_s00213_009_1558_8
crossref_primary_10_1523_JNEUROSCI_2219_18_2018
crossref_primary_10_1038_nn_3014
crossref_primary_10_1177_0269881109349841
crossref_primary_10_1016_j_neuropharm_2012_07_025
crossref_primary_10_1007_s00213_012_2689_x
crossref_primary_10_1097_FBP_0b013e3283305eb4
crossref_primary_10_1016_j_cobeha_2024_101402
crossref_primary_10_1038_npp_2012_6
crossref_primary_10_1097_FBP_0b013e328333a2bb
crossref_primary_10_3724_SP_J_1042_2021_01345
crossref_primary_10_1017_S1092852914000133
crossref_primary_10_3389_fpsyt_2022_960238
crossref_primary_10_1007_s00213_013_3390_4
crossref_primary_10_1007_s00213_011_2579_7
crossref_primary_10_1016_j_nicl_2017_04_010
crossref_primary_10_1111_ejn_12289
crossref_primary_10_1016_j_neubiorev_2010_04_008
crossref_primary_10_1016_j_cub_2024_09_064
crossref_primary_10_1016_j_neuropharm_2013_05_022
crossref_primary_10_1016_j_ejphar_2009_10_019
crossref_primary_10_1016_j_semcdb_2009_01_002
crossref_primary_10_1016_j_neuropharm_2008_07_019
crossref_primary_10_1093_ijnp_pyab041
crossref_primary_10_1159_000362840
crossref_primary_10_1016_j_drugalcdep_2010_11_030
crossref_primary_10_1007_s00213_008_1182_z
crossref_primary_10_1007_s00213_015_4141_5
crossref_primary_10_1016_j_pneurobio_2013_06_005
crossref_primary_10_1016_j_biopsych_2011_06_033
crossref_primary_10_1038_npp_2010_165
crossref_primary_10_1038_npp_2012_111
crossref_primary_10_1007_s00213_015_3865_6
crossref_primary_10_1016_j_neubiorev_2013_02_010
crossref_primary_10_1016_j_neubiorev_2015_04_009
crossref_primary_10_1016_j_pbb_2008_08_006
crossref_primary_10_1016_j_conb_2013_05_001
crossref_primary_10_1007_s11920_011_0224_0
crossref_primary_10_1093_cercor_bhw312
crossref_primary_10_1162_jocn_a_01011
crossref_primary_10_1038_s41386_019_0381_0
crossref_primary_10_1007_s00213_022_06174_w
crossref_primary_10_1523_JNEUROSCI_3765_09_2009
crossref_primary_10_1016_j_neuropharm_2013_05_033
crossref_primary_10_3758_s13415_018_0638_9
crossref_primary_10_1016_j_pnpbp_2018_01_010
crossref_primary_10_3389_fnbeh_2017_00237
crossref_primary_10_1523_JNEUROSCI_2730_11_2012
crossref_primary_10_1016_j_medcli_2008_07_019
crossref_primary_10_1002_mds_22836
crossref_primary_10_1186_s40359_020_00482_6
crossref_primary_10_1016_j_neubiorev_2013_07_003
crossref_primary_10_1016_j_neuropharm_2014_06_003
crossref_primary_10_3758_s13420_017_0274_1
crossref_primary_10_1523_JNEUROSCI_5066_10_2011
crossref_primary_10_1097_ADM_0000000000000066
crossref_primary_10_1146_annurev_psych_122414_033457
crossref_primary_10_1152_jn_00180_2020
crossref_primary_10_3389_fpsyt_2023_1208120
crossref_primary_10_1007_s00213_011_2181_z
crossref_primary_10_1007_s00213_011_2372_7
crossref_primary_10_1111_acer_12393
crossref_primary_10_1111_j_1530_0277_2011_01668_x
crossref_primary_10_1162_CPSY_a_00002
crossref_primary_10_1523_JNEUROSCI_5426_10_2011
crossref_primary_10_3758_s13428_021_01739_7
crossref_primary_10_1038_npp_2009_142
crossref_primary_10_1038_nrn3104
crossref_primary_10_1016_j_drugalcdep_2018_08_008
crossref_primary_10_1016_j_biopsych_2008_12_008
crossref_primary_10_1098_rstb_2008_0089
crossref_primary_10_1016_j_neubiorev_2015_06_015
crossref_primary_10_1111_ejn_13961
crossref_primary_10_1038_s41386_022_01387_1
crossref_primary_10_1016_j_biopsych_2012_05_001
crossref_primary_10_1016_j_neubiorev_2008_08_008
crossref_primary_10_1016_j_bbr_2012_03_005
crossref_primary_10_1016_j_biopsych_2011_01_008
crossref_primary_10_1038_npp_2014_335
crossref_primary_10_1016_j_addbeh_2020_106534
crossref_primary_10_1007_s00213_012_2746_5
crossref_primary_10_1007_s00213_019_05330_z
crossref_primary_10_1111_j_1749_6632_2010_05899_x
crossref_primary_10_1093_brain_awac366
crossref_primary_10_1111_adb_12143
crossref_primary_10_1016_j_neubiorev_2017_05_019
crossref_primary_10_1111_nyas_14929
Cites_doi 10.1001/archpsyc.61.1.73
10.1177/0269881105057000
10.1016/S0893-133X(01)00355-4
10.1007/s002130100911
10.1038/sj.npp.1301337
10.1126/science.3155875
10.1017/S0033291702007018
10.1016/j.addbeh.2004.04.015
10.1001/archpsyc.63.1.90
10.1073/pnas.85.14.5274
10.1136/jnnp.57.12.1518
10.1016/0014-2999(85)90179-7
10.1016/j.addbeh.2004.10.010
10.1016/0028-3908(83)90075-8
10.1016/j.drugalcdep.2005.02.002
10.1038/sj.npp.1301225
10.1146/annurev.pa.33.040193.003231
10.1093/cercor/10.3.326
10.1046/j.1471-4159.1997.68052032.x
10.1126/science.1121218
10.1111/j.1360-0443.2005.01160.x
10.1016/j.neulet.2005.03.053
10.1126/science.1094987
10.1007/s00213-005-0104-6
10.1162/089892904322926791
10.1038/sj.npp.1300663
10.1007/PL00005483
10.1016/S0893-6080(02)00052-7
10.1111/j.1460-9568.2004.03274.x
10.1016/0091-3057(81)90401-9
10.1016/S0376-8716(98)00072-6
10.1016/j.biopsych.2003.09.011
10.1038/sj.npp.1300247
10.2165/00003088-200443030-00002
10.1016/S0893-133X(00)00097-X
10.1523/JNEUROSCI.3321-04.2004
10.1080/09595230600657758
10.1016/S0028-3932(99)00035-4
10.1016/0740-5472(92)90062-S
10.1093/cercor/10.3.284
10.1016/S1364-6613(98)01240-6
10.1016/S0028-3932(99)00103-7
10.1111/j.1360-0443.1995.tb02199.x
10.1038/nn1579
10.1016/S0376-8716(01)00206-X
10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1
10.1111/j.1360-0443.2006.01314.x
10.1126/science.275.5306.1593
10.1007/BF00439267
10.1016/j.pnpbp.2007.08.040
10.1016/j.addbeh.2006.06.032
10.1523/JNEUROSCI.15-02-01308.1995
10.1136/jnnp.58.5.598
10.1523/JNEUROSCI.23-21-07839.2003
10.18356/58c4f2e4-en
10.1046/j.1360-0443.1995.9056072.x
10.1523/JNEUROSCI.16-03-01230.1996
10.1523/JNEUROSCI.22-11-04563.2002
ContentType Journal Article
Copyright Springer-Verlag 2007
2008 INIST-CNRS
Springer-Verlag 2008
Springer-Verlag 2007 2007
Copyright_xml – notice: Springer-Verlag 2007
– notice: 2008 INIST-CNRS
– notice: Springer-Verlag 2008
– notice: Springer-Verlag 2007 2007
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QG
7QR
7RV
7TK
7X7
7XB
88E
88G
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
K9.
KB0
M0S
M1P
M2M
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1007/s00213-007-1051-1
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Animal Behavior Abstracts
Chemoreception Abstracts
Nursing & Allied Health Database
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Databases
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Psychology Collection
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
Animal Behavior Abstracts
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Neurosciences Abstracts
ProQuest One Psychology
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1432-2072
EndPage 431
ExternalDocumentID PMC3785131
1456226621
18214445
20233315
10_1007_s00213_007_1051_1
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GrantInformation_xml – fundername: Wellcome Trust
  grantid: 076274
– fundername: Medical Research Council
  grantid: G0001354
– fundername: Wellcome Trust
  grantid: 076274/Z/04/Z
– fundername: Wellcome Trust :
  grantid: 076274 || WT
GroupedDBID -4W
-BR
.55
3SX
40D
40E
95.
95~
ABMNI
AGWIL
ALMA_UNASSIGNED_HOLDINGS
KOW
N2Q
R9-
RHV
SBY
SOJ
X7M
~EX
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QG
7QR
7RV
7TK
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GNUQQ
K9.
M1P
M2M
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
ID FETCH-LOGICAL-c485t-acf41f21e5edff84a1c6eda384e4524eccf295fdbf0d2c73027ca6d00d1223ef3
IEDL.DBID U2A
ISSN 0033-3158
IngestDate Thu Aug 21 17:55:41 EDT 2025
Fri Jul 11 09:32:58 EDT 2025
Fri Jul 11 12:03:16 EDT 2025
Sat Aug 16 22:50:40 EDT 2025
Fri May 30 11:01:11 EDT 2025
Tue Sep 20 21:42:20 EDT 2022
Thu Apr 24 22:51:56 EDT 2025
Tue Jul 01 04:16:32 EDT 2025
Fri Feb 21 02:34:17 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Amphetamines
Opiates
Perseveration
Cocaine
Probabilistic reversal learning
Serotonin
Amphetamine derivatives
Human
CNS stimulant
Psychotropic
Ester
Chronic
Probabilistic reversal learning, Serotonin
Reversal learning
Neurotransmitter
Amfetamine
Probability learning
Drug of abuse
Language English
License http://www.springer.com/tdm
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c485t-acf41f21e5edff84a1c6eda384e4524eccf295fdbf0d2c73027ca6d00d1223ef3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 18214445
PQID 218958182
PQPubID 47309
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3785131
proquest_miscellaneous_68566240
proquest_miscellaneous_20603047
proquest_journals_218958182
pubmed_primary_18214445
pascalfrancis_primary_20233315
crossref_primary_10_1007_s00213_007_1051_1
crossref_citationtrail_10_1007_s00213_007_1051_1
springer_journals_10_1007_s00213_007_1051_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2008-04-01
PublicationDateYYYYMMDD 2008-04-01
PublicationDate_xml – month: 04
  year: 2008
  text: 2008-04-01
  day: 01
PublicationDecade 2000
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Berlin
– name: Germany
– name: Heidelberg
PublicationTitle Psychopharmacologia
PublicationTitleAbbrev Psychopharmacology
PublicationTitleAlternate Psychopharmacology (Berl)
PublicationYear 2008
Publisher Springer-Verlag
Springer
Springer Nature B.V
Publisher_xml – name: Springer-Verlag
– name: Springer
– name: Springer Nature B.V
References Daw, Kakade, Dayan (CR9) 2002; 15
Evers, Cools, Clark, van der Veen, Jolles, Sahakian, Robbins (CR14) 2005; 30
McGregor, Srisurapanont, Jittiwutikarn, Laobhripatr, Wongtan, White (CR39) 2005; 100
Kuczenski, Segal, Cho, Melega (CR31) 1995; 15
Segal, Kuczenski, O’Neil, Melega, Cho (CR57) 2003; 28
Clarke, Dalley, Crofts, Robbins, Roberts (CR7) 2004; 304
Fillmore, Rush (CR17) 2006; 20
Swainson, Rogers, Sahakian, Summers, Polkey, Robbins (CR61) 2000; 38
Verdejo-Garcia, Perales, Perez-Garcia (CR65) 2007; 32
Arnsten (CR2) 1998; 2
Howell, Hoffman, Votaw, Landrum, Wilcox, Lindsey (CR26) 2002; 159
Rolls, Hornak, Wade, Mcgrath (CR54) 1994; 57
Annett, Ridley, Gamble, Baker (CR1) 1983; 81
London, Simon, Berman, Mandelkern, Lichtman, Bramen, Shinn, Miotto, Learn, Dong, Matochik, Kurian, Newton, Woods, Rawson, Ling (CR36) 2004; 61
Forman, Dougherty, Casey, Siegle, Braver, Barch, Stenger, Wick-Hull, Pisarov, Lorensen (CR18) 2004; 55
(CR62) 1999
Clark, Roiser, Cools, Rubinsztein, Sahakian, Robbins (CR6) 2005; 182
De Win, Reneman, Jager, Vlieger, Olabarriaga, Lavini, Bisschops, Majoie, Booij, den Heeten, Van den Brink (CR11) 2007; 32
Beck, Steer, Brown (CR3) 1996
Schoenbaum, Saddoris, Ramus, Shaham, Setlow (CR55) 2004; 19
de la Torre, Farre, Navarro, Pacifici, Zuccaro, Pichini (CR10) 2004; 43
Filip, Frankowska, Zaniewska, Golda, Przegalinski (CR15) 2005; 57
Fillmore, Rush (CR16) 2002; 66
Schultz, Dayan, Montague (CR56) 1997; 275
Hester, Garavan (CR23) 2004; 24
Jentsch, Taylor (CR27) 1999; 146
Lee, Zhou, Luo, Yuen, Ruan, Weng (CR35) 2005; 382
Howell (CR25) 1997
Johanson, Fischman (CR29) 1989; 41
Lange, Sahakian, Quinn, Marsden, Robbins (CR5) 1995; 8
McLellan, Kushner, Metzger, Peters, Smith, Grissom, Pettinati, Argeriou (CR40) 1992; 9
Ridley, Haystead, Baker (CR51) 1981; 14
Lawrence, Sahakian, Rogers, Hodges, Robbins (CR33) 1999; 37
Porrino, Smith, Nader, Beveridge (CR49) 2007; 31
Cools, Clark, Owen, Robbins (CR8) 2002; 22
Kaufman, Ross, Stein, Garavan (CR30) 2003; 23
CR19
Lee, Groman, London, Jentsch (CR34) 2007; 32
Sekine, Ouchi, Takei, Yoshikawa, Nakamura, Futatsubashi, Okada, Minabe, Suzuki, Iwata, Tsuchiya, Tsukada, Iyo, Mori (CR59) 2006; 63
Verdejo-Garcia, Lopez-Torrecillas, Aguilar de Arcos, Perez-Garcia (CR64) 2005; 30
Everitt, Robbins (CR13) 2005; 8
Jentsch, Olausson, De La Garza, Taylor (CR28) 2002; 26
Gouzoulis-Mayfrank, Daumann (CR21) 2006; 101
White, Kalivas (CR66) 1998; 51
Rolls (CR53) 2000; 10
Seiden, Sabol, Ricaurte (CR58) 1993; 33
Lyvers (CR38) 2006; 25
Nelson (CR43) 1982
Ridley, Haystead, Baker (CR52) 1981; 14
Kuczenski, Segal (CR32) 1997; 68
Ricaurte, Fuller, Perry, Seiden, Schuster (CR50) 1983; 22
Graveland, Williams, Difiglia (CR22) 1985; 227
Hornak, O’Doherty, Bramham, Rolls, Morris, Bullock, Polkey (CR24) 2004; 16
Peltier, Li, Lytle, Taylor, Emmett-Oglesby (CR47) 1996; 277
Chamberlain, Muller, Blackwell, Clark, Robbins, Sahakian (CR4) 2006; 311
Di Chiara, Imperato (CR12) 1988; 85
Ornstein, Iddon, Baldacchino, Sahakian, London, Everitt, Robbins (CR44) 2000; 23
Peat, Warren, Bakhit, Gibb (CR46) 1985; 116
Murphy, Michael, Robbins, Sahakian (CR42) 2003; 33
Sofuoglu, Dudish-Poulsen, Poling, Mooney, Hatsukami (CR60) 2005; 30
Lyons, Friedman, Nader, Porrino (CR37) 1996; 16
Fillmore, Rush (CR67) 2006; 20
Gossop, Darke, Griffiths, Hando, Powis, Hall, Strang (CR20) 1995; 90
Monterosso, Aron, Cordova, Xu, London (CR41) 2005; 79
Porrino, Lyons (CR48) 2000; 10
(CR63) 2007
Patton, Stanford, Barratt (CR45) 1995; 51
DC Howell (1051_CR25) 1997
AJ Verdejo-Garcia (1051_CR65) 2007; 32
HE Nelson (1051_CR43) 1982
R Cools (1051_CR8) 2002; 22
E Gouzoulis-Mayfrank (1051_CR21) 2006; 101
GA Ricaurte (1051_CR50) 1983; 22
RM Ridley (1051_CR52) 1981; 14
DS Segal (1051_CR57) 2003; 28
CE Johanson (1051_CR29) 1989; 41
JH Patton (1051_CR45) 1995; 51
LJ Porrino (1051_CR49) 2007; 31
R Kuczenski (1051_CR32) 1997; 68
MT Fillmore (1051_CR16) 2002; 66
Y Sekine (1051_CR59) 2006; 63
AT Beck (1051_CR3) 1996
MA Peat (1051_CR46) 1985; 116
FJ White (1051_CR66) 1998; 51
M Lyvers (1051_CR38) 2006; 25
B Lee (1051_CR34) 2007; 32
C McGregor (1051_CR39) 2005; 100
D Lyons (1051_CR37) 1996; 16
LS Seiden (1051_CR58) 1993; 33
GA Graveland (1051_CR22) 1985; 227
LJ Porrino (1051_CR48) 2000; 10
J Hornak (1051_CR24) 2004; 16
AFT Arnsten (1051_CR2) 1998; 2
G Chiara Di (1051_CR12) 1988; 85
United Nations Office on Drugs and Crime (1051_CR63) 2007
EAT Evers (1051_CR14) 2005; 30
MT Fillmore (1051_CR17) 2006; 20
AD Lawrence (1051_CR33) 1999; 37
TJ Ornstein (1051_CR44) 2000; 23
R Hester (1051_CR23) 2004; 24
SD Forman (1051_CR18) 2004; 55
FC Murphy (1051_CR42) 2003; 33
W Schultz (1051_CR56) 1997; 275
MML Win De (1051_CR11) 2007; 32
TMC Lee (1051_CR35) 2005; 382
AT McLellan (1051_CR40) 1992; 9
R Swainson (1051_CR61) 2000; 38
1051_CR67
AJ Verdejo-Garcia (1051_CR64) 2005; 30
ED London (1051_CR36) 2004; 61
ET Rolls (1051_CR53) 2000; 10
RM Ridley (1051_CR51) 1981; 14
L Clark (1051_CR6) 2005; 182
ND Daw (1051_CR9) 2002; 15
M Filip (1051_CR15) 2005; 57
M Gossop (1051_CR20) 1995; 90
HF Clarke (1051_CR7) 2004; 304
R Torre de la (1051_CR10) 2004; 43
JD Jentsch (1051_CR28) 2002; 26
ET Rolls (1051_CR54) 1994; 57
JN Kaufman (1051_CR30) 2003; 23
M Sofuoglu (1051_CR60) 2005; 30
1051_CR19
SR Chamberlain (1051_CR4) 2006; 311
LE Annett (1051_CR1) 1983; 81
BJ Everitt (1051_CR13) 2005; 8
JR Monterosso (1051_CR41) 2005; 79
LL Howell (1051_CR26) 2002; 159
U.K.Department of Health (1051_CR62) 1999
1051_CR5
R Kuczenski (1051_CR31) 1995; 15
JD Jentsch (1051_CR27) 1999; 146
RL Peltier (1051_CR47) 1996; 277
G Schoenbaum (1051_CR55) 2004; 19
References_xml – volume: 61
  start-page: 73
  year: 2004
  end-page: 84
  ident: CR36
  article-title: Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.61.1.73
– volume: 20
  start-page: 24
  year: 2006
  end-page: 32
  ident: CR17
  article-title: Polydrug abusers display impaired discrimination-reversal learning in a model of behavioural control
  publication-title: J Psychopharmacol
  doi: 10.1177/0269881105057000
– volume: 26
  start-page: 183
  year: 2002
  end-page: 190
  ident: CR28
  article-title: Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(01)00355-4
– volume: 15
  start-page: 1308
  year: 1995
  end-page: 1317
  ident: CR31
  article-title: Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine
  publication-title: J Neurosci
– volume: 159
  start-page: 154
  year: 2002
  end-page: 160
  ident: CR26
  article-title: Cocaine-induced brain activation determined by positron emission tomography neuroimaging in conscious rhesus monkeys
  publication-title: Psychopharmacology
  doi: 10.1007/s002130100911
– volume: 16
  start-page: 1230
  year: 1996
  end-page: 1238
  ident: CR37
  article-title: Cocaine alters cerebral metabolism within the ventral striatum and limbic cortex of monkeys
  publication-title: J Neurosci
– volume: 57
  start-page: 685
  year: 2005
  end-page: 700
  ident: CR15
  article-title: The serotonergic system and its role in cocaine addiction
  publication-title: Pharmacol Rep
– volume: 32
  start-page: 2125
  issue: 10
  year: 2007
  end-page: 2134
  ident: CR34
  article-title: Dopamine D2/D3 dopamine receptors play a specific role in reversal of a learned visual discrimination in monkeys
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301337
– volume: 227
  start-page: 770
  year: 1985
  end-page: 773
  ident: CR22
  article-title: Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntingtons-disease
  publication-title: Science
  doi: 10.1126/science.3155875
– volume: 33
  start-page: 455
  year: 2003
  end-page: 467
  ident: CR42
  article-title: Neuropsychological impairment in patients with major depressive disorder: the effects of feedback on task performance
  publication-title: Psychol Med
  doi: 10.1017/S0033291702007018
– year: 2007
  ident: CR63
  publication-title: World drug report 2007
– volume: 30
  start-page: 89
  year: 2005
  end-page: 101
  ident: CR64
  article-title: Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: A multiple regression analysis
  publication-title: Addict Behav
  doi: 10.1016/j.addbeh.2004.04.015
– volume: 63
  start-page: 90
  year: 2006
  end-page: 100
  ident: CR59
  article-title: Brain serotonin transporter density and aggression in abstinent methamphetamine abusers
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.63.1.90
– volume: 85
  start-page: 5274
  year: 1988
  end-page: 5278
  ident: CR12
  article-title: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.85.14.5274
– volume: 20
  start-page: 24
  year: 2006
  end-page: 32
  ident: CR67
  article-title: Polydrug abusers display impaired discrimination-reversal learning in a model of behavioural control
  publication-title: J Psychopharmacol
– volume: 57
  start-page: 1518
  year: 1994
  end-page: 1524
  ident: CR54
  article-title: Emotion-related learning in patients with social and emotional changes associated with frontal-lobe damage
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.57.12.1518
– year: 1996
  ident: CR3
  publication-title: Manual for Beck Depression Inventory-II
– volume: 116
  start-page: 11
  year: 1985
  end-page: 16
  ident: CR46
  article-title: The acute effects of methamphetamine, amphetamine and -chloroamphetamine on the cortical serotonergic system of the rat brain: evidence for differences in the effects of methamphetamine and amphetamine
  publication-title: Eur j pharmacol
  doi: 10.1016/0014-2999(85)90179-7
– volume: 30
  start-page: 1125
  year: 2005
  end-page: 1134
  ident: CR60
  article-title: The effect of individual cocaine withdrawal symptoms on outcomes in cocaine users
  publication-title: Addict Behav
  doi: 10.1016/j.addbeh.2004.10.010
– volume: 22
  start-page: 1165
  year: 1983
  end-page: 1169
  ident: CR50
  article-title: Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of -methamphetamine and -amphetamine
  publication-title: Neuropharmacology
  doi: 10.1016/0028-3908(83)90075-8
– volume: 41
  start-page: 3
  year: 1989
  end-page: 52
  ident: CR29
  article-title: The pharmacology of cocaine related to its abuse
  publication-title: Pharmacol Rev
– ident: CR19
– volume: 79
  start-page: 273
  year: 2005
  end-page: 277
  ident: CR41
  article-title: Deficits in response inhibition associated with chronic methamphetamine abuse
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2005.02.002
– volume: 32
  start-page: 458
  year: 2007
  end-page: 470
  ident: CR11
  article-title: A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301225
– volume: 33
  start-page: 639
  year: 1993
  end-page: 676
  ident: CR58
  article-title: Amphetamine: effects on catecholamine systems and behavior
  publication-title: Annu Rev Pharmacol Toxicol
  doi: 10.1146/annurev.pa.33.040193.003231
– volume: 10
  start-page: 326
  year: 2000
  end-page: 333
  ident: CR48
  article-title: Orbital and medial prefrontal cortex and psychostimulant abuse: studies in animal models
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/10.3.326
– year: 1997
  ident: CR25
  publication-title: Statistical methods for psychology
– volume: 68
  start-page: 2032
  year: 1997
  end-page: 2037
  ident: CR32
  article-title: Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.1997.68052032.x
– volume: 311
  start-page: 861
  year: 2006
  end-page: 863
  ident: CR4
  article-title: Neurochemical modulation of response inhibition and probabilistic learning in humans
  publication-title: Science
  doi: 10.1126/science.1121218
– volume: 100
  start-page: 1320
  year: 2005
  end-page: 1329
  ident: CR39
  article-title: The nature, time course and severity of methamphetamine withdrawal
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2005.01160.x
– volume: 22
  start-page: 4563
  year: 2002
  end-page: 4567
  ident: CR8
  article-title: Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging
  publication-title: J Neurosci
– volume: 382
  start-page: 211
  year: 2005
  end-page: 216
  ident: CR35
  article-title: Neural activity associated with cognitive regulation in heroin users: a fMRI study
  publication-title: Neurosci lett
  doi: 10.1016/j.neulet.2005.03.053
– volume: 8
  start-page: 598
  year: 1995
  end-page: 606
  ident: CR5
  article-title: Comparison of executive and visuospatial memory function in Huntington’s disease and dementia of Alzheimer type matched for degree of dementia
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 304
  start-page: 878
  year: 2004
  end-page: 880
  ident: CR7
  article-title: Cognitive inflexibility after prefrontal serotonin depletion
  publication-title: Science
  doi: 10.1126/science.1094987
– volume: 182
  start-page: 570
  year: 2005
  end-page: 578
  ident: CR6
  article-title: Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-005-0104-6
– volume: 16
  start-page: 463
  year: 2004
  end-page: 478
  ident: CR24
  article-title: Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans
  publication-title: J cogn neurosci
  doi: 10.1162/089892904322926791
– volume: 30
  start-page: 1138
  year: 2005
  end-page: 1147
  ident: CR14
  article-title: Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300663
– volume: 146
  start-page: 373
  year: 1999
  end-page: 390
  ident: CR27
  article-title: Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli
  publication-title: Psychopharmacology
  doi: 10.1007/PL00005483
– volume: 23
  start-page: 7839
  year: 2003
  end-page: 7843
  ident: CR30
  article-title: Cingulate hypoactivity in cocaine users during a GO–NOGO task as revealed by event-related functional magnetic resonance imaging
  publication-title: J Neurosci
– volume: 15
  start-page: 603
  year: 2002
  end-page: 616
  ident: CR9
  article-title: Opponent interactions between serotonin and dopamine
  publication-title: Neural netw
  doi: 10.1016/S0893-6080(02)00052-7
– volume: 19
  start-page: 1997
  year: 2004
  end-page: 2002
  ident: CR55
  article-title: Cocaine-experienced rats exhibit learning deficits in a task sensitive to orbitofrontal cortex lesions
  publication-title: Eur J Neurosci
  doi: 10.1111/j.1460-9568.2004.03274.x
– volume: 14
  start-page: 345
  year: 1981
  end-page: 351
  ident: CR52
  article-title: An analysis of visual object reversal learning in the marmoset after amphetamine and haloperidol
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/0091-3057(81)90401-9
– volume: 51
  start-page: 141
  year: 1998
  end-page: 153
  ident: CR66
  article-title: Neuroadaptations involved in amphetamine and cocaine addiction
  publication-title: Drug Alcohol Depend
  doi: 10.1016/S0376-8716(98)00072-6
– volume: 14
  start-page: 345
  year: 1981
  end-page: 351
  ident: CR51
  article-title: An analysis of visual object reversal-learning in the marmoset after amphetamine and haloperidol
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/0091-3057(81)90401-9
– volume: 55
  start-page: 531
  year: 2004
  end-page: 537
  ident: CR18
  article-title: Opiate addicts lack error-dependent activation of rostral anterior cingulate
  publication-title: Biol Psychiat
  doi: 10.1016/j.biopsych.2003.09.011
– volume: 28
  start-page: 1730
  year: 2003
  end-page: 1740
  ident: CR57
  article-title: Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300247
– volume: 43
  start-page: 157
  year: 2004
  end-page: 185
  ident: CR10
  article-title: Clinical pharmacokinetics of amfetamine and related substances—monitoring in conventional and non-conventional matrices
  publication-title: Clin pharmacokinet
  doi: 10.2165/00003088-200443030-00002
– volume: 277
  start-page: 212
  year: 1996
  end-page: 218
  ident: CR47
  article-title: Chronic -amphetamine or methamphetamine produces cross-tolerance to the discriminative and reinforcing stimulus effects of cocaine
  publication-title: J Pharmacol Exp Ther
– volume: 23
  start-page: 113
  year: 2000
  end-page: 126
  ident: CR44
  article-title: Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(00)00097-X
– volume: 24
  start-page: 11017
  year: 2004
  end-page: 11022
  ident: CR23
  article-title: Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.3321-04.2004
– volume: 25
  start-page: 269
  year: 2006
  end-page: 276
  ident: CR38
  article-title: Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues
  publication-title: Drug Alcohol Rev
  doi: 10.1080/09595230600657758
– volume: 37
  start-page: 1359
  year: 1999
  end-page: 1374
  ident: CR33
  article-title: Discrimination, reversal, and shift learning in Huntington’s disease: mechanisms of impaired response selection
  publication-title: Neuropsychologia
  doi: 10.1016/S0028-3932(99)00035-4
– volume: 9
  start-page: 199
  year: 1992
  end-page: 213
  ident: CR40
  article-title: The fifth edition of the addiction severity index
  publication-title: J Subst Abuse Treat
  doi: 10.1016/0740-5472(92)90062-S
– volume: 10
  start-page: 284
  year: 2000
  end-page: 294
  ident: CR53
  article-title: The orbitofrontal cortex and reward
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/10.3.284
– volume: 2
  start-page: 436
  year: 1998
  end-page: 447
  ident: CR2
  article-title: Catecholamine modulation of prefrontal cortical cognitive function
  publication-title: Trends Cogn Sci
  doi: 10.1016/S1364-6613(98)01240-6
– volume: 38
  start-page: 596
  year: 2000
  end-page: 612
  ident: CR61
  article-title: Probabilistic learning and reversal deficits in patients with Parkinson’s disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication
  publication-title: Neuropsychologia
  doi: 10.1016/S0028-3932(99)00103-7
– volume: 90
  start-page: 607
  year: 1995
  end-page: 614
  ident: CR20
  article-title: The severity of dependence scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.1995.tb02199.x
– volume: 8
  start-page: 1481
  year: 2005
  end-page: 1489
  ident: CR13
  article-title: Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
  publication-title: Nat Neurosci
  doi: 10.1038/nn1579
– volume: 66
  start-page: 265
  year: 2002
  end-page: 273
  ident: CR16
  article-title: Impaired inhibitory control of behavior in chronic cocaine users
  publication-title: Drug Alcohol Depend
  doi: 10.1016/S0376-8716(01)00206-X
– volume: 51
  start-page: 768
  year: 1995
  end-page: 774
  ident: CR45
  article-title: Factor structure of the Barratt Impulsiveness Scale
  publication-title: J Clin Psychol
  doi: 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1
– year: 1982
  ident: CR43
  publication-title: National adult reading test manual
– year: 1999
  ident: CR62
  publication-title: Drug misuse and dependence—guidelines on clinical management
– volume: 101
  start-page: 348
  year: 2006
  end-page: 361
  ident: CR21
  article-title: Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2006.01314.x
– volume: 275
  start-page: 1593
  year: 1997
  end-page: 1599
  ident: CR56
  article-title: A neural substrate of prediction and reward
  publication-title: Science
  doi: 10.1126/science.275.5306.1593
– volume: 81
  start-page: 18
  year: 1983
  end-page: 23
  ident: CR1
  article-title: Behavioral effects of intracerebral amphetamine in the marmoset
  publication-title: Psychopharmacology
  doi: 10.1007/BF00439267
– volume: 31
  start-page: 1593
  year: 2007
  end-page: 1600
  ident: CR49
  article-title: The effects of cocaine: a shifting target over the course of addiction
  publication-title: Prog neuro-psychopharmacol biol psychiatry
  doi: 10.1016/j.pnpbp.2007.08.040
– volume: 32
  start-page: 950
  year: 2007
  end-page: 966
  ident: CR65
  article-title: Cognitive impulsivity in cocaine and heroin polysubstance abusers
  publication-title: Addict Behav
  doi: 10.1016/j.addbeh.2006.06.032
– volume: 33
  start-page: 455
  year: 2003
  ident: 1051_CR42
  publication-title: Psychol Med
  doi: 10.1017/S0033291702007018
– volume: 15
  start-page: 603
  year: 2002
  ident: 1051_CR9
  publication-title: Neural netw
  doi: 10.1016/S0893-6080(02)00052-7
– volume: 55
  start-page: 531
  year: 2004
  ident: 1051_CR18
  publication-title: Biol Psychiat
  doi: 10.1016/j.biopsych.2003.09.011
– volume: 23
  start-page: 113
  year: 2000
  ident: 1051_CR44
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(00)00097-X
– volume: 24
  start-page: 11017
  year: 2004
  ident: 1051_CR23
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.3321-04.2004
– volume: 28
  start-page: 1730
  year: 2003
  ident: 1051_CR57
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300247
– volume-title: Drug misuse and dependence—guidelines on clinical management
  year: 1999
  ident: 1051_CR62
– volume: 61
  start-page: 73
  year: 2004
  ident: 1051_CR36
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.61.1.73
– volume: 51
  start-page: 768
  year: 1995
  ident: 1051_CR45
  publication-title: J Clin Psychol
  doi: 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1
– volume: 15
  start-page: 1308
  year: 1995
  ident: 1051_CR31
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.15-02-01308.1995
– volume: 33
  start-page: 639
  year: 1993
  ident: 1051_CR58
  publication-title: Annu Rev Pharmacol Toxicol
  doi: 10.1146/annurev.pa.33.040193.003231
– volume: 182
  start-page: 570
  year: 2005
  ident: 1051_CR6
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-005-0104-6
– volume: 9
  start-page: 199
  year: 1992
  ident: 1051_CR40
  publication-title: J Subst Abuse Treat
  doi: 10.1016/0740-5472(92)90062-S
– volume: 16
  start-page: 463
  year: 2004
  ident: 1051_CR24
  publication-title: J cogn neurosci
  doi: 10.1162/089892904322926791
– ident: 1051_CR5
  doi: 10.1136/jnnp.58.5.598
– volume-title: Manual for Beck Depression Inventory-II
  year: 1996
  ident: 1051_CR3
– volume: 23
  start-page: 7839
  year: 2003
  ident: 1051_CR30
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.23-21-07839.2003
– volume: 22
  start-page: 1165
  year: 1983
  ident: 1051_CR50
  publication-title: Neuropharmacology
  doi: 10.1016/0028-3908(83)90075-8
– volume: 57
  start-page: 685
  year: 2005
  ident: 1051_CR15
  publication-title: Pharmacol Rep
– volume: 10
  start-page: 326
  year: 2000
  ident: 1051_CR48
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/10.3.326
– volume: 68
  start-page: 2032
  year: 1997
  ident: 1051_CR32
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.1997.68052032.x
– volume: 14
  start-page: 345
  year: 1981
  ident: 1051_CR51
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/0091-3057(81)90401-9
– volume: 8
  start-page: 1481
  year: 2005
  ident: 1051_CR13
  publication-title: Nat Neurosci
  doi: 10.1038/nn1579
– volume: 43
  start-page: 157
  year: 2004
  ident: 1051_CR10
  publication-title: Clin pharmacokinet
  doi: 10.2165/00003088-200443030-00002
– ident: 1051_CR19
– volume: 38
  start-page: 596
  year: 2000
  ident: 1051_CR61
  publication-title: Neuropsychologia
  doi: 10.1016/S0028-3932(99)00103-7
– volume: 2
  start-page: 436
  year: 1998
  ident: 1051_CR2
  publication-title: Trends Cogn Sci
  doi: 10.1016/S1364-6613(98)01240-6
– volume: 100
  start-page: 1320
  year: 2005
  ident: 1051_CR39
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2005.01160.x
– volume: 63
  start-page: 90
  year: 2006
  ident: 1051_CR59
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.63.1.90
– volume: 37
  start-page: 1359
  year: 1999
  ident: 1051_CR33
  publication-title: Neuropsychologia
  doi: 10.1016/S0028-3932(99)00035-4
– volume: 30
  start-page: 89
  year: 2005
  ident: 1051_CR64
  publication-title: Addict Behav
  doi: 10.1016/j.addbeh.2004.04.015
– volume: 32
  start-page: 458
  year: 2007
  ident: 1051_CR11
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301225
– volume: 19
  start-page: 1997
  year: 2004
  ident: 1051_CR55
  publication-title: Eur J Neurosci
  doi: 10.1111/j.1460-9568.2004.03274.x
– volume: 32
  start-page: 2125
  issue: 10
  year: 2007
  ident: 1051_CR34
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301337
– volume: 85
  start-page: 5274
  year: 1988
  ident: 1051_CR12
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.85.14.5274
– volume: 30
  start-page: 1125
  year: 2005
  ident: 1051_CR60
  publication-title: Addict Behav
  doi: 10.1016/j.addbeh.2004.10.010
– volume: 26
  start-page: 183
  year: 2002
  ident: 1051_CR28
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(01)00355-4
– volume: 227
  start-page: 770
  year: 1985
  ident: 1051_CR22
  publication-title: Science
  doi: 10.1126/science.3155875
– ident: 1051_CR67
  doi: 10.1177/0269881105057000
– volume: 304
  start-page: 878
  year: 2004
  ident: 1051_CR7
  publication-title: Science
  doi: 10.1126/science.1094987
– volume: 14
  start-page: 345
  year: 1981
  ident: 1051_CR52
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/0091-3057(81)90401-9
– volume: 79
  start-page: 273
  year: 2005
  ident: 1051_CR41
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2005.02.002
– volume-title: Statistical methods for psychology
  year: 1997
  ident: 1051_CR25
– volume: 146
  start-page: 373
  year: 1999
  ident: 1051_CR27
  publication-title: Psychopharmacology
  doi: 10.1007/PL00005483
– volume: 25
  start-page: 269
  year: 2006
  ident: 1051_CR38
  publication-title: Drug Alcohol Rev
  doi: 10.1080/09595230600657758
– volume-title: National adult reading test manual
  year: 1982
  ident: 1051_CR43
– volume: 41
  start-page: 3
  year: 1989
  ident: 1051_CR29
  publication-title: Pharmacol Rev
– volume: 159
  start-page: 154
  year: 2002
  ident: 1051_CR26
  publication-title: Psychopharmacology
  doi: 10.1007/s002130100911
– volume: 277
  start-page: 212
  year: 1996
  ident: 1051_CR47
  publication-title: J Pharmacol Exp Ther
– volume: 66
  start-page: 265
  year: 2002
  ident: 1051_CR16
  publication-title: Drug Alcohol Depend
  doi: 10.1016/S0376-8716(01)00206-X
– volume: 382
  start-page: 211
  year: 2005
  ident: 1051_CR35
  publication-title: Neurosci lett
  doi: 10.1016/j.neulet.2005.03.053
– volume: 116
  start-page: 11
  year: 1985
  ident: 1051_CR46
  publication-title: Eur j pharmacol
  doi: 10.1016/0014-2999(85)90179-7
– volume: 101
  start-page: 348
  year: 2006
  ident: 1051_CR21
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2006.01314.x
– volume: 311
  start-page: 861
  year: 2006
  ident: 1051_CR4
  publication-title: Science
  doi: 10.1126/science.1121218
– volume-title: World drug report 2007
  year: 2007
  ident: 1051_CR63
  doi: 10.18356/58c4f2e4-en
– volume: 30
  start-page: 1138
  year: 2005
  ident: 1051_CR14
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300663
– volume: 90
  start-page: 607
  year: 1995
  ident: 1051_CR20
  publication-title: Addiction
  doi: 10.1046/j.1360-0443.1995.9056072.x
– volume: 275
  start-page: 1593
  year: 1997
  ident: 1051_CR56
  publication-title: Science
  doi: 10.1126/science.275.5306.1593
– volume: 31
  start-page: 1593
  year: 2007
  ident: 1051_CR49
  publication-title: Prog neuro-psychopharmacol biol psychiatry
  doi: 10.1016/j.pnpbp.2007.08.040
– volume: 51
  start-page: 141
  year: 1998
  ident: 1051_CR66
  publication-title: Drug Alcohol Depend
  doi: 10.1016/S0376-8716(98)00072-6
– volume: 81
  start-page: 18
  year: 1983
  ident: 1051_CR1
  publication-title: Psychopharmacology
  doi: 10.1007/BF00439267
– volume: 20
  start-page: 24
  year: 2006
  ident: 1051_CR17
  publication-title: J Psychopharmacol
  doi: 10.1177/0269881105057000
– volume: 16
  start-page: 1230
  year: 1996
  ident: 1051_CR37
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.16-03-01230.1996
– volume: 57
  start-page: 1518
  year: 1994
  ident: 1051_CR54
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.57.12.1518
– volume: 10
  start-page: 284
  year: 2000
  ident: 1051_CR53
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/10.3.284
– volume: 32
  start-page: 950
  year: 2007
  ident: 1051_CR65
  publication-title: Addict Behav
  doi: 10.1016/j.addbeh.2006.06.032
– volume: 22
  start-page: 4563
  year: 2002
  ident: 1051_CR8
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-11-04563.2002
SSID ssj0000484
ssj0068394
Score 2.370653
Snippet Rationale Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain...
Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We...
Rationale: Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 421
SubjectTerms Adolescent
Adult
Aged
Amphetamine - toxicity
Amphetamine-Related Disorders - psychology
Amphetamines
Appetitive Behavior - drug effects
Association Learning - drug effects
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Brain research
Central Nervous System Stimulants - toxicity
Choice Behavior - drug effects
Cocaine
Cocaine - toxicity
Cocaine-Related Disorders - psychology
Cognition & reasoning
Dopamine Uptake Inhibitors - toxicity
Drug use
Female
Humans
Male
Medical sciences
Middle Aged
Motivation
Neuropharmacology
Neurosciences
Opioid-Related Disorders - psychology
Original Investigation
Pharmacology
Pharmacology. Drug treatments
Pharmacology/Toxicology
Probability Learning
Psychiatry
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Receptors, Serotonin - drug effects
Reversal Learning - drug effects
Reward
Stereotyped Behavior - drug effects
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZpAqUQSps-4qZJdSg5tDGVLNnynkoJDaGQkkMCezOyHnQh9W5jbyH_vjOWbLNtk8uyu5LwYz5pPjSjbwh5b_OZMzZTqRZcpJLDR-1rlkrtjGYeGK7GfciL78X5tfw2z-cxN6eNaZXDmtgv1HZpcI_8E7iiWQ7eJfu8-pVi0SgMrsYKGo_IDiqXIajVXE0LscQzmOFHAUQgKDILPE-Wl0OEk_WCohnWOEC5RMBoyjd81O5Kt_C6fKhz8T8i-m8-5V9B1d5XnT0jTyPJpF8CKp6TLdfskccXMYy-R44vg2D13Qm9ms5ftSf0mF5OUtZ3L4iL2rkUlk0NQ2m97miz7KiJ_2sAg-v0T2xbt44uWqqjwZ2luMlLV0Aw3W8XFMbpbZ-Tiw6TLhraVwhsX5Lrs69Xp-dpLMyQGlnmXaqNl9xn3OXOel9KzU3hrBaldDLPJKDCZ7Pc29ozmxmFoVGjC8uY5cBGnBevyHazbNw-oUAfea0yMxPMSl_aWpdKaQesiHmhVZEQNpiiMlG1HItn3FSj3nJvvQq_ovUqnpAP45BVkOx4qPPRhn3HEVhWXgBQEnIwGLyK07utRjAm5N3YCvMSgy26ccs1dGEFRp3V_T2KEqg0EKqEvA7wme62RCE7CddWG8AaO6Am-GZLs_jRa4MLBRRawGN9HCA43fW9L-HNg894QJ6EJBlMV3pLtrvbtTsEJtbVR_18-wMIVjEp
  priority: 102
  providerName: ProQuest
Title Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans
URI https://link.springer.com/article/10.1007/s00213-007-1051-1
https://www.ncbi.nlm.nih.gov/pubmed/18214445
https://www.proquest.com/docview/218958182
https://www.proquest.com/docview/20603047
https://www.proquest.com/docview/68566240
https://pubmed.ncbi.nlm.nih.gov/PMC3785131
Volume 197
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED-2FsagjK378rplehh92GqwLdlyHpORrGw0hNFA9mRkfdDA5oTaKfS_352_QrZ2sJc4iSTH8Z10P-vufgfwwcRDq00kfcVD7osQX3KXB75QVqvAIcJVtA95MUvOF-LrMl62edxlF-3euSTrlbpPdiNzxH3aWkNMEPr4yHMY46M7xXEtotFu-RWUedl8SND8NzzMnLLI4rTza951vj3LdLRRJd4k11S3uAt-_h1F-YcrtbZQ06fwpIWWbNTowjN4YItjeHTROs-P4XTe0FTfnrHLXdZVecZO2XxHYH37HGzLmMtwsVQ4lOXbihXriun2e4UqYCv1i9q2pWWrkqlWzNYw2tplG4SV9sY2vOLsuo7EJTPJVgWr6wKWL2AxnVx-Pvfbcgy-Fmlc-Uo7EbootLE1zqVChTqxRvFUWBFHAnXBRcPYmdwFJtKSHKJaJSYITIgYxDr-Eg6KdWFfA0PQGOYy0kMeGOFSk6tUSmURCwWOK5l4EHSiyHTLVU4lM35mPctyLb2M3pL0stCDj_2QTUPU8a_Ogz359iOomDxHRfHgpBN41k7qMkM0NIwR4EQevO9bcTaSi0UVdr3FLkFCvmZ5f48kRQCNMMqDV4367K42Jfo6gb8t9xSr70BM4PstxeqqZgTnEoEzx7_1qVPB3VXfexPe_FfvE3jchMpQ0NJbOKiut_Yd4rEqH8BDuZQDOBxNx-MZHb_8-DbB43gym38f1LPzN0pVM20
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIgESQlBeptDuAXqAWqzttdc5IISAKqVN1UMq5eau9yEigRNqB5QfxX9kxq8oQHvrJUqyu443MzvzeWf2G4CXJh5YbULpqyiIfBHgS-5y7gtlteIOEa6ifcjRSTI8E18m8WQDfndnYSitsrOJtaE2M0175G_RFQ1i9C7h-_kPn4pGUXC1q6DRaMWRXf7CJ7by3eEnFO-rMDz4PP449NuiAr4WaVz5SjsRuDCwsTXOpUIFOrFGRamwIg4FzsiFg9iZ3HETaklhPa0Sw7kJ0JNaF-F1b8BN9LucnvXkRK4Mv6Azn82HBIFHwwAd0fm1OO0iqrwmMA2ppgLRM-Ka8IM1n3h3rkoUj2vqavwP-P6bv_lXELf2jQf34V4LatmHRgsfwIYttuDWqA3bb8HeaUOQvdxn49V5r3Kf7bHTFXX28iHYlquXoZlWOJTli4oVs4rp9nuFymcr9Z3aFqVl05KpVsGsYbSpzOYIaO1P2zCas4s6B5gcNJsWrK5IWD6Cs2uR2WPYLGaFfQoM4WqQy1APIm6ES02uUimVRRTGXaRk4gHvRJHpliWdinV8y3p-51p6Gb0l6WWBB6_7IfOGIuSqzjtr8u1HUBn7CBXFg-1O4FlrTsqsV34PdvtWtAMU3FGFnS2wC08oyi0v75GkCN0RwHnwpFGf1d2mRJwn8LflmmL1HYiDfL2lmH6tucgjiZA9wmm96VRwddeX_gnPrpzjLtwejkfH2fHhydE23GkSdChV6jlsVhcL-wJRYJXv1GuPwfl1L_Y_HmtwRg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVKqQEILyMoV2D9AD1OraXj9yQAhoo5bSKEKt1JtZ70NEAifUDig_jX_HjJ8K0N56iZLsruPNzM583pn9BuCFDodGaT92ZeAFrvDwJbMZd4U0SnKLCFfSPuTpODo6Fx8vwos1-N2ehaG0ytYmVoZazxTtke-jKxqG6F38fdtkRUwORm_nP1wqIEWB1raaRq0hJ2b5C5_eijfHByjql74_Ojz7cOQ2BQZcJZKwdKWywrO-Z0KjrU2E9FRktAwSYUToC5yd9Yeh1Znl2lcxhfiUjDTn2kOvamyA170F6zE9FA1g_f3hePK5dwOCToDWHyKEITUfdECn2cKkja_yis7UpwoLRNaIK8T1VjzknbksUFi2rrLxPxj8bzbnXyHdylOO7sHdBuKyd7VO3oc1k2_CxmkTxN-E3UlNl73cY2f96a9ij-2ySU-kvXwApmHuZWi0JQ5l2aJk-axkqvleoiqaUn6ntkVh2LRgslE3oxltMbM5wlvz09T85uyyyggmd82mOavqExYP4fxGpPYIBvksN0-AIXj1sthXw4BrYROdySSOpUFMxm0g48gB3ooiVQ1nOpXu-JZ2bM-V9FJ6S9JLPQdedUPmNWHIdZ23V-TbjaCi9gEqigNbrcDTxrgUabcUHNjpWtEqUKhH5ma2wC48oph3fHWPKEEgj3DOgce1-vR3mxCNnsDfjlcUq-tAjOSrLfn0a8VMHsQI4AOc1utWBfu7vvJPeHrtHHdgAxd6-ul4fLIFt-tsHcqbegaD8nJhniMkLLPtZvEx-HLT6_0Pkuh14Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chronic+cocaine+but+not+chronic+amphetamine+use+is+associated+with+perseverative+responding+in+humans&rft.jtitle=Psychopharmacology&rft.au=Ersche%2C+Karen+D&rft.au=Roiser%2C+Jonathan+P&rft.au=Robbins%2C+Trevor+W&rft.au=Sahakian%2C+Barbara+J&rft.date=2008-04-01&rft.issn=0033-3158&rft.volume=197&rft.issue=3&rft.spage=421&rft_id=info:doi/10.1007%2Fs00213-007-1051-1&rft_id=info%3Apmid%2F18214445&rft.externalDocID=18214445
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon